TP53 and breast cancer: A protocol similar to the one employed in the present study was used by Van Dycke et al. 26, who showed that chronic circadian disruption resulting from weekly alternating light–dark cycles increased breast cancer development in p53(R270H/+) WAPCre conditional mutant mice.